T. Shimada

Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy

M. Akiyama, Y. Okano, K. Izumi, 2022, Rheumatology International.

Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study

Y. Okano, K. Izumi, H. Oshima, 2022, Scientific Reports.

Dropped head in systemic sclerosis: a case based review

M. Akiyama, Y. Okano, H. Takei, 2021, Rheumatology International.

Acute Encephalitis in Primary Sjögren's Syndrome: A Case Report and Literature Review.

M. Akiyama, Y. Okano, H. Takei, 2021, Modern rheumatology case reports.

Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins

M. Akiyama, Y. Okano, S. Matsubara, 2022, Immunological medicine.

Allergic disorders and their risk factors in primary Sjögren's syndrome

Y. Okano, K. Izumi, H. Oshima, 2023, The World Allergy Organization journal.

COVID‐19 pneumonia can cause irreversible lung damage in dermatomyositis with pre‐existing interstitial lung disease

M. Akiyama, Y. Okano, H. Takei, 2021, International journal of rheumatic diseases.

Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy

M. Akiyama, Y. Okano, H. Takei, 2022, Internal medicine.